SAB BIOTHERAPEUTICS, INC. Shares Outstanding (Cover Page)
SAB BIOTHERAPEUTICS, INC. (SABS) had Shares Outstanding (Cover Page) of 90.99 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 90.99M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 76.46M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 50.95M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 47.61M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 90.99M shares 10-Q · filed 2026-08-06 |
| 2026-05-06 | 76.46M shares 10-Q · filed 2026-05-12 |
| 2026-03-02 | 50.95M shares 10-K · filed 2026-03-09 |
| 2025-11-10 | 47.61M shares 10-Q · filed 2025-11-14 |
| 2025-08-01 | 10.41M shares 10-Q · filed 2025-08-07 |
| 2025-05-02 | 9.29M shares 10-Q · filed 2025-05-09 |
| 2025-03-21 | 9.29M shares 10-K · filed 2025-03-31 |
| 2024-11-01 | 9.23M shares 10-Q · filed 2024-11-06 |
| 2024-08-02 | 9.23M shares 10-Q · filed 2024-08-08 |
| 2024-05-16 | 9.23M shares 10-Q · filed 2024-05-20 |
| 2024-03-18 | 9.23M shares 10-K · filed 2024-03-29 |
| 2023-10-31 | 52.32M shares 10-Q · filed 2023-11-13 |
| 2023-07-31 | 52.32M shares 10-Q · filed 2023-08-21 |
| 2023-05-05 | 50.40M shares 10-Q · filed 2023-05-15 |
| 2023-03-28 | 50.40M shares 10-K/A · filed 2023-04-28 |
| 2022-11-03 | 43.03M shares 10-Q · filed 2022-11-14 |
| 2022-07-29 | 43.03M shares 10-Q · filed 2022-08-10 |
| 2022-04-28 | 42.96M shares 10-Q · filed 2022-05-12 |
| 2022-03-28 | 42.96M shares 10-K · filed 2022-03-29 |
| 2022-03-25 | 42.96M shares 10-K/A · filed 2023-04-28 |
| 2021-11-15 | 43.47M shares 10-Q · filed 2021-11-22 |
| 2021-08-09 | 14.79M shares 10-Q · filed 2021-08-09 |
| 2021-05-20 | 14.79M shares 10-Q · filed 2021-05-21 |
| 2021-03-29 | 14.79M shares 10-K · filed 2021-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |